Key facts
- This page summarizes Caroline Tillett's Form 4 filing for Kenvue Inc. (KVUE).
- 12 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 17 Dec 2025, 17:48.
Caroline Tillett - 15 Dec 2025 Form 4 Insider Report for Kenvue Inc. (KVUE)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- KVUE
- Reported as of
- 15 Dec 2025
- Net transaction value
- -$299,599
- SEC form
- 4
- Accepted by SEC
- 17 Dec 2025, 17:48:25 UTC
- Prior SEC filing
- 03 Dec 2025
- Next SEC filing
- 04 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alla Berenshteyn, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Caroline Tillett filed Form 4 for Kenvue Inc. (KVUE) on 17 Dec 2025.
Change
- Previous filing in this sequence was filed on 03 Dec 2025.
- Current net transaction value: -$299,599.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001966949
Primary reporting owner
Tillett Caroline
- Relationship
- Chief Scientific Officer
- Address
- 1 KENVUE WAY, SUMMIT
- Signature
- /s/ Alla Berenshteyn, as attorney-in-fact
- Signature date
- 17 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KVUE
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +23,158
- Change %
- +52%
- Price
- $0.000000
- Shares after
- 68,038
- Date
- 15 Dec 2025
- Ownership
- Direct
KVUE
transaction
Common Stock
Tax liability
- Transaction value
- $204,699
- Shares
- -11,846
- Change %
- -17%
- Price
- $17.28
- Shares after
- 56,192
- Date
- 15 Dec 2025
- Ownership
- Direct
- Footnotes
- F1
KVUE
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,994
- Change %
- +5.3%
- Price
- $0.000000
- Shares after
- 59,186
- Date
- 15 Dec 2025
- Ownership
- Direct
KVUE
transaction
Common Stock
Tax liability
- Transaction value
- $26,473
- Shares
- -1,532
- Change %
- -2.6%
- Price
- $17.28
- Shares after
- 57,654
- Date
- 15 Dec 2025
- Ownership
- Direct
- Footnotes
- F1
KVUE
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +4,399
- Change %
- +7.6%
- Price
- $0.000000
- Shares after
- 62,053
- Date
- 15 Dec 2025
- Ownership
- Direct
KVUE
transaction
Common Stock
Tax liability
- Transaction value
- $38,740
- Shares
- -2,251
- Change %
- -3.6%
- Price
- $17.21
- Shares after
- 59,802
- Date
- 15 Dec 2025
- Ownership
- Direct
- Footnotes
- F1
KVUE
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +3,372
- Change %
- +5.6%
- Price
- $0.000000
- Shares after
- 63,173
- Date
- 15 Dec 2025
- Ownership
- Direct
KVUE
transaction
Common Stock
Tax liability
- Transaction value
- $29,687
- Shares
- -1,725
- Change %
- -2.7%
- Price
- $17.21
- Shares after
- 61,448
- Date
- 15 Dec 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KVUE
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -23,158
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,158
- Exercise price
- Footnotes
- F2, F3, F4
KVUE
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,994
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,994
- Exercise price
- Footnotes
- F4, F5, F6
KVUE
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,399
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 4,399
- Date
- 15 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,399
- Exercise price
- Footnotes
- F4, F7, F8, F9
KVUE
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,372
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 6,740
- Date
- 15 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,372
- Exercise price
- Footnotes
- F4, F7, F9, F10
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 10 footnotes
Footnote F1
Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").
Footnote F2
These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level.
Footnote F3
This award was scheduled to vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date but vesting was accelerated in order to mitigate the adverse impact to the Issuer and the Reporting Person of Section 280G of the Internal Revenue Code in connection with the pending transaction between the Issuer and Kimberly-Clark Corporation ("Section 280G Mitigation").
Footnote F4
This award will be subject to clawback in the event it is determined that the Reporting Person would not have ultimately vested in the award notwithstanding the acceleration reflected herein.
Footnote F5
These RSUs were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer, were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.
Footnote F6
This award was scheduled to vest in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date but the vesting of the portion reflected herein was accelerated from 02/13/2026 in connection with the Section 280G Mitigation.
Footnote F7
These units correspond 1 for 1 with the Company's common stock.
Footnote F8
This award was scheduled to vest in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/05/2026 in connection with the 280G Mitigation.
Footnote F9
Includes RSUs acquired as dividend equivalents.
Footnote F10
This award was scheduled to vest in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/10/2026 in connection with the Section 280G Mitigation.